Carrageenan–Acyclovir Complex and Its Liposomal Form
International Journal of Molecular Sciences · 09.04.2026 · 27 (8) · 3367
DOI: 10.3390/ijms27083367 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.04.2026. Verfasst von Irina M Yermak und 8 weiteren Autor:innen. Beteiligte Einrichtung: G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-Eastern Branch of the Russian Academy of Sciences (FEB RAS), 100 Let Vladivostoku Prosp. …. Hauptthemen laut MEDLINE: Liposomes, Acyclovir, Antiviral Agents, Carrageenan. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Sulfated polysaccharides, carrageenans (CRGs) derived from Chondrus armatus, were used as mucoadhesive matrices for incorporating the antiviral drug acyclovir (ACV). Through IR spectroscopy and quantum-chemical calculations, it was demonstrated that CRGs interact with ACV, forming complexes via intermolecular hydrogen bonding and coordination interactions, with an enthalpy of approximately 15–20 kcal/mol. The monomodal ζ-potential distribution observed in the CRG/ACV mixture confirmed the successful formation of this complex. The antiviral efficacy of the CRG/ACV complex was evaluated during the early stages of herpes simple virus (HSV-1) infection, focusing on its ability to inhibit the cytopathic effects of the virus on host cells. Notably, CRGs enhanced antiviral activity by allowing a reduction in the ACV dosage. Unlike ACV alone, the CRG complex exhibited a prophylactic effect, with therapeutic efficacy comparable to that of ACV. When incorporated into liposomes, the CRG/ACV complex displayed excellent mucoadhesive properties. This liposomal formulation demonstrated notable antiviral activity against infected cells with selective index (SI) 344 and a heightened prophylactic effect (SI 128) compared to the complex alone. Overall, these new antiviral compounds show promise in selectively inhibiting viral adsorption and replication processes without adversely affecting the host organism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-Eastern Branch of the Russian Academy of Sciences (FEB RAS), 100 Let Vladivostoku Prosp. 159, 690022 Vladivostok, Russia.
- G.P. Somov Institute of Epidemiology and Microbiology, Rospotrebnadzor, Selskya St. 1, 690087 Vladivostok, Russia.
ORCID-Profile: Irina M Yermak, Natalya V Krylova, Viktoriya N Davydova
Förderung
- Russian Science Foundation
Zitieren
APA
Yermak, I. M., Glazunov, V. P., Krylova, N. V., Gorbach, V. I., Kravchenko, A. O., Volod'ko, A. V., Davydova, V. N., Chistyulin, D. K., & Shchelkanov, M. Y. (2026). Carrageenan–Acyclovir Complex and Its Liposomal Form. International Journal of Molecular Sciences, 27(8), 3367. https://doi.org/10.3390/ijms27083367
Vancouver
Yermak IM, Glazunov VP, Krylova NV, Gorbach VI, Kravchenko AO, Volod'ko AV, et al. Carrageenan–Acyclovir Complex and Its Liposomal Form. International Journal of Molecular Sciences. 2026;27(8):3367. doi:10.3390/ijms27083367
BibTeX
@article{Yermak2026,
author = {Yermak, Irina M and Glazunov, Valery P and Krylova, Natalya V and Gorbach, Vladimir I and Kravchenko, Anna O and Volod'ko, Alexandra V and Davydova, Viktoriya N and Chistyulin, Dmitry K and Shchelkanov, Mikhail Y},
title = {Carrageenan–Acyclovir Complex and Its Liposomal Form},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {8},
pages = {3367},
doi = {10.3390/ijms27083367}
}
EUVIMED